Headline News about Biontech Se ADR![]() ![]() ![]() ![]() ![]() ![]()
BioNTech Starts Dosing In Herpes Vaccine Candidate Study
December 21, 2022
Via Benzinga
Will Investors Notice Exciting Sign On BioNTech's Chart?
December 19, 2022
Via Benzinga
![]()
BioNTech, Ryvu Therapeutics Join Forces For Immuno-Modulatory Candidates
November 30, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
December 15, 2022
Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
![]() ![]() ![]() ![]()
FDA Authorizes Pfizer/BioNTech And Moderna's Bivalent COVID Shots For 6 Months Old
December 08, 2022
Via Benzinga
![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|